LYMPHOMA
Saul A. Rosenberg, MD
Maureen Lyles D'Ambrogio Professor Emeritus, Stanford School of Medicine
Saul A. Rosenberg, MD, is a pioneer in the use of curative chemoradiation to treat patients with Hodgkin lymphoma and helped launch the medical oncology field at Stanford.